Parkland Corporation Announces Completion of Conrad & Bischoff Inc. Acquisition and April 2021 Dividend

Written by Customer Service on April 13, 2021. Posted in Mergers And Acquisitions.

CALGARY, Alberta, April 13, 2021 (GLOBE NEWSWIRE) — Parkland Corporation (“Parkland”) (TSX:PKI) announces that through its wholly owned U.S. subsidiaries (collectively, “Parkland USA”), it has completed the previously announced acquisition of Conrad & Bischoff Inc. and its related companies (collectively, “C&B”). C&B is a well-established retail, commercial, wholesale and lubricants business and establishes Parkland’s fourth U.S. Regional Operating Center (“ROC”) in Idaho Falls, ID. Family owned and operated since 1959, C&B’s operations are concentrated in the fast-growing markets of Idaho and western Wyoming with additional distribution capability into Utah, Nevada, Montana and other states. Please see Parkland’s press release dated February 26, 2021 for more information about this acquisition. Parkland...

Journal for ImmunoTherapy of Cancer Publishes Phase 1 Clinical Research Showing Belapectin, Galectin Therapeutics’ Galectin-3 Inhibitor, Enhances Tumor Response in Combination with Anti-PD-1 Therapy

Written by Customer Service on April 13, 2021. Posted in Public Companies.

NORCROSS, Ga., April 13, 2021 (GLOBE NEWSWIRE) — Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that a paper published in the peer-reviewed Journal for ImmunoTherapy of Cancer (JITC), the highest ranked fully open access immunology journal, provides further clinical evidence that using belapectin, a potent galectin-3 inhibitor, in combination with pembrolizumab (KEYTRUDA®), a PD-1 inhibitor, significantly enhances tumor response to immunotherapy in patients with advanced metastatic melanoma (MM) and head and neck squamous cell carcinoma (HNSCC). The paper, titled “Enhancing Clinical and Immunological Effects of anti-PD-1 with Belapectin, a Galectin-3 Inhibitor” (doi:10.1136/jitc-2021-002371) describes results from an ongoing Phase 1 clinical study, a...

Madison Pacific Properties Inc. announces the results for the six months ended February 28, 2021, declares special dividend and announces appointment of director

Written by Customer Service on April 13, 2021. Posted in Public Companies.

VANCOUVER, British Columbia, April 13, 2021 (GLOBE NEWSWIRE) — Madison Pacific Properties Inc. (the Company) (TSX: MPC and MPC.C), a Vancouver-based real estate company announces the results of operations for the six months ended February 28, 2021. The results reported are pursuant to International Financial Reporting Standards (IFRS) for public companies. For the six months ended February 28, 2021, the Company is reporting net income of $22.3 million (2020: $14.7 million); cash flows from operating activities before changes in non-cash operating balances of $4.9 million (2020: $7.0 million); and income per share of $0.34 (2020: $0.25). Included in net income is an after-tax net gain from the fair value adjustment on investment properties of $14.9 million (2020: $9.9 million). The Company currently owns approximately $628 million...

Cluny Capital Corp. Announces Receipt of Conditional Approval and Files Filing Statement for Its Qualifying Transaction

Written by Customer Service on April 13, 2021. Posted in Public Companies.

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES TORONTO, April 13, 2021 (GLOBE NEWSWIRE) — Cluny Capital Corp. (the “Company” or “Cluny”) (TSXV:CLN.H), a capital pool company pursuant to Policy 2.4 of the TSX Venture Exchange (the “Exchange”), is pleased to announce that it has received conditional approval from the Exchange for the closing of its business combination (the “Transaction”) with Teonan Biomedical Inc. (“Teonan”), previously announced in its press releases dated July 30, 2020 and November 30, 2020 and the Company has filed its filing statement dated April 8, 2021 in connection with the Transaction (the “Filing Statement”). The Filing Statement is available under the Company’s profile on SEDAR at www.sedar.com. The Transaction is intended to constitute the Company’s Qualifying...

Asia Broadband Plans Legal Action Against Misleading Internet Posts

Written by Customer Service on April 13, 2021. Posted in Public Companies.

LAS VEGAS, April 13, 2021 (GLOBE NEWSWIRE) — via InvestorWire – Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) announced today that the Company is planning legal action against numerous misleading and defamatory Internet posts on various public platforms and websites over the past several months. A prime example today was an Internet post mimicking a press release referencing a Letter of Intent with New World Gold Corp. that was not authorized and not submitted by AABB’s management. Additionally, AABB has no association or affiliation with New World Gold Corp. or the website publisher. “The entire AABB management team is determined to pursue the parties responsible for the misinformation and defamatory assaults aimed at the Company recently and going forward,” expressed AABB CEO James Gilbert. About Asia Broadband Asia...

Hallmark Financial Announces Intent to Pursue IPO of its Specialty Commercial Business

Written by Customer Service on April 13, 2021. Posted in Public Companies.

DALLAS, April 13, 2021 (GLOBE NEWSWIRE) — Hallmark Financial Services, Inc. (the “Company” or “Hallmark Financial”), a property and casualty insurance company comprised of three business segments (Specialty Commercial, Standard Commercial, and Personal), today announced that, based on its previously announced evaluation of the separation of the Specialty Commercial business segment, it plans to pursue an initial public offering (“IPO”) of a non-controlling ownership stake in the core businesses within the Company’s Specialty Commercial business segment, as a separate company named Hallmark Specialty Group, Inc. (“Hallmark Specialty Group”). While the number of shares of Hallmark Specialty Group to be offered and the price range for the offering have not yet been determined, the offered shares are expected to represent an economic...

Neptune Digital Assets Files Final Base Shelf Prospectus

Written by Customer Service on April 13, 2021. Posted in Public Companies.

VANCOUVER, British Columbia, April 13, 2021 (GLOBE NEWSWIRE) — Neptune Digital Assets Corp. (TSX-V:NDA) (OTC:NPPTF) (FSE:1NW) (“Neptune” or the “Company“) is pleased to announce that it has filed a final short form base shelf prospectus (the “Prospectus”) with the securities regulatory authorities in British Columbia and Alberta. The Prospectus, when made effective, will enable the Company to make offerings of up to C$100 million of common shares, warrants, subscription receipts, units and debt securities, or a combination thereof, of the Company from time to time, separately or together, in amounts, at prices and on terms to be determined based on market conditions at the time of the offering and as set out in an accompanying prospectus supplement, during the 25-month period that the Prospectus remains effective. About...

Knight to Present at the 2021 Bloom Burton & Co. Healthcare Virtual Investor Conference

Written by Customer Service on April 13, 2021. Posted in Public Companies.

MONTREAL, April 13, 2021 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Operating Officer, is scheduled to present a corporate update at the Bloom Burton & Co. Healthcare Investor Conference on Tuesday, April 20, 2021 at 9:30 a.m. ET that will be held virtually. To register, please visit the event’s registration page at the following link: Register. A copy of the presentation will be available at www.gud-knight.com. About Knight Therapeutics Inc. Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing and commercializing innovative pharmaceutical products for Canada and Latin America. Knight owns Biotoscana...

Knight présentera à la conférence virtuelle des investisseurs en santé Bloom Burton & Co. 2021

Written by Customer Service on April 13, 2021. Posted in Public Companies.

MONTRÉAL, 13 avr. 2021 (GLOBE NEWSWIRE) — Thérapeutique Knight inc. (TSX : GUD), société pharmaceutique spécialisée panaméricaine (ex-ÉU) et chef de file, a annoncé aujourd’hui que Samira Sakhia, présidente et chef de l’exploitation, présentera une mise à jour corporative à la conférence des investisseurs en santé Bloom Burton & Co., le mardi 20 avril 2021 à 9 h 30 HE, qui se tiendra virtuellement. Pour vous inscrire, veuillez consulter la page d’inscription de l’événement au lien suivant : S’inscrire. Une copie de la présentation sera disponible sur www.gud-knight.com. À propos de Thérapeutique Knight inc. Thérapeutique Knight inc., établie à Montréal, au Canada, est une société pharmaceutique spécialisée qui concentre ses efforts sur l’acquisition ou l’obtention sous licence de droits de distribution de produits pharmaceutiques...

Klappir Grænar Lausnir hf. – helstu niðurstöður aðalfundar 2021

Written by Customer Service on April 13, 2021. Posted in Public Companies.

Helstu niðurstöður aðalfundar Klappa Grænna Lausna hf. árið 2021 Á aðalfundi Klappa Grænna Lausna hf., sem fram fór þann 13. apríl 2021, voru eftirfarandi tillögur samþykktar auk þess sem ný stjórn var kjörin. I. Tillögur sem samþykktar voru á aðalfundinum Ársreikningur félagsins fyrir liðið starfsár var kynntur og staðfestur Tillaga um ráðstöfun afkomu félagsins vegna reikningsársins 2020 Samþykkt var tillaga stjórnar við aðalfund um að ekki yrði greiddur arður vegna rekstrarársins 2020, en að tap ársins yrði fært til lækkunar á eigin fé félagsins. Kosning endurskoðunarfélags Svofelld tillaga var samþykkt: „Stjórn félagsins leggur til við aðalfund að Deloitte ehf. verði kjörið endurskoðunarfirma Klappa Grænna Lausna hf.“ Ákvörðun um þóknun stjórnarmanna Stjórn lagði til að stjórnarlaun yrðu óbreytt eða sem nemur kr. 50.000 fyrir...

Day: April 13, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice